Key result
Risperidone use is associated with the development of neuroleptic malignant syndrome.
Key points are not available for this paper at this time.
Supports NMS monitoring with risperidone; leaves open causality and comparative risks.
Levin, Gary M. PharmD; Lazowick, Andrea L. PharmD; Powell, Hannah S. MD Author Information
No takes yet. Share an insight, caveat, or question.
Levin et al. (1996) studied this question. Risperidone use is associated with the development of neuroleptic malignant syndrome.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: